Edit
Jenner Institute University of Oxford
https://www.jenner.ac.uk/Last activity: 21.05.2020
Active
Development of innovative human and veterinary vaccines against major global diseases such as malaria, TB, HIV, Ebola.
Location: United Kingdom, England, Oxford
Employees: 11-50
Investors 1
| Date | Name | Website |
| 17.07.2021 | CARB-X | carb-x.org |
Mentions in press and media 3
| Date | Title | Description |
| 21.05.2020 | U.S. gives up to $1.2 billion to AstraZeneca for Covid-19 vaccine | The race over funding and access to a Covid-19 vaccine is heating up as the U.S. government pledged to commit up to $1.2 billion to AstraZeneca (AZN) for its efforts and obtain at least 300 million doses of any vaccine by October. And as pa... |
| 30.03.2017 | SpyBiotech, which makes a ‘superglue’ for vaccines, raises £4M from GV and Oxford | The startup bug has hit the world of biotechnology, and the latest victim is a business that is building a “super glue,” coincidentally, for bug-combating vaccines. SpyBiotech — a startup spun out of Oxford University that has developed a w... |
| 17.03.2015 | Emergent Biosolutions’ latest product could make Ebola vaccines stronger | Even as the Ebola crisis fades in and out of the headlines, the quest to develop a vaccine against the virus continues. On Monday, officials announced another role that Baltimore’s burgeoning biotech community is playing in the development ... |